FINWIRES · TerminalLIVE
FINWIRES

Budweiser APAC's Profit Slips in Q1 as China Spend Weighs; Shares Rise Nearly 2%

作者

-- Budweiser Brewing Company APAC (HKG:1876) posted a slight decline in profit attributable to equity holders in the first quarter as revenue fell despite a marginal increase in volumes.

The brewer reported profit attributable to equity holders of $226 million for the three months ended March 31, compared with $234 million a year earlier, according to a Tuesday Hong Kong bourse filing.

Earnings per share declined to $1.68 from $1.76 a year earlier, though it came in well above the Visible Alpha consensus estimate of $0.02.

Revenue fell 0.7% to $1.49 billion, topping the Visible Alpha estimate of $1.44 billion, while revenue per hectoliter declined 0.8% due to increased investments in China.

Analysts at Jefferies said sales were 3% above estimates, supported by both East and West, led by stronger India volumes.

India delivered strong double-digit growth in both volumes and revenue, supported by continued premiumization across its portfolio.

In China, volumes declined 1.5%, though the pace of decline narrowed, while revenue fell 4% amid increased investments in channels and brand activation.

The increased investments in China were mainly directed toward supporting wholesalers, expanding the in-home route-to-market and online-to-offline (O2O) channels, and stepping up brand and marketing initiatives.

This included higher spending on campaigns such as the nationwide rollout of Budweiser Magnum, supported by a partnership with Erling Haaland and the FIFA World Cup platform.

In South Korea, volumes declined by low-teens while revenue fell by mid-single-digits against a high base, reflecting shipment phasing ahead of a price increase in April 2025.

Separately, the company flagged ongoing legal and tax-related issues at its South Korean unit, Oriental Brewery, which has recorded $86 million in cumulative exceptional charges linked to customs audit claims that it is contesting.

The matter escalated in 2025 with indictments tied to alleged embezzlement, commercial bribery, and customs tax issues related to malt imports.

Several entities and senior executives were also named as joint defendants, with proceedings ongoing.

The subsidiary has also received tax assessments totaling about $71 million from Korean authorities for prior years and has prepaid around $62 million while it challenges portions of the claims.

"We believe investors will focus on: 1) strategy in China; 2) raw material cost trends and margin outlook; 3) price hike potential in APAC East amid a soft industry; and 4) potential in India," said Jefferies analysts in a note to clients.

Shares of Budweiser APAC were up marginally in Tuesday morning trade.

相关文章

Asia

Smartgroup对澳大利亚政府决定将电动汽车折扣维持一年表示欢迎,股价创两年新高。

Smartgroup(ASX:SIQ)周二发表声明,对澳大利亚政府决定将电动汽车购车折扣政策延长一年表示欢迎。 该公司指出,这项政策为充电行业提供了确定性,支持对澳大利亚充电基础设施的进一步投资,并有助于构建电动汽车普及所需的充电网络。 受此消息提振,Smartgroup股价在近期交易中上涨7%,创下两年来的新高。

$ASX:SIQ
Asia

市场传闻:澳航CEO对燃油供应前景“更加乐观”

据彭博新闻周二报道,澳航(ASX:QAN)首席执行官瓦妮莎·哈德森表示,公司对燃油供应前景“更加乐观”。 报道称,哈德森在麦格理澳大利亚会议上表示,公司已签订燃油供应协议,直至6月中旬。 哈德森指出,尽管燃油价格高企,但澳航的国内和国际航空旅行需求依然强劲。 (市场动态新闻来源于与全球市场专业人士的对话。这些信息被认为来自可靠来源,但可能包含传闻和推测。准确性无法保证。)

$ASX:QAN
Asia

Sigma Healthcare宣布,旗下Chemist Warehouse品牌将根据与某药房集团达成的协议进入英国市场;股价上涨4%。

Sigma Healthcare(ASX:SIG)周二宣布与Greenlight Healthcare签署谅解备忘录,根据该备忘录,Chemist Warehouse品牌将进入英国市场。 该公司在一份声明中表示,将收购这家员工持股的药房集团旗下多家门店75%的股份,Greenlight将继续持有剩余的25%股份。 Sigma将获得Chemist Warehouse品牌和知识产权的授权,并提供零售支持;Greenlight将提供配药和专业服务以及后台支持。 合资企业的第一阶段将专注于品牌重塑,并首先开发至多五家门店,首家门店将位于伦敦市东北部的霍克斯顿街。如果第一阶段取得成功,第二阶段可能会开发更多门店。双方计划确定现有的Greenlight药房,并在适当情况下将其改造或搬迁至Chemist Warehouse门店。 Sigma Healthcare的股票在周二的近期交易中上涨了近4%。

$ASX:SIG